Unknown

Dataset Information

0

Variations in the SDN Loop of Class A Beta-Lactamases: A Study of the Molecular Mechanism of BlaC (Mycobacterium tuberculosis) to Alter the Stability and Catalytic Activity Towards Antibiotic Resistance of MBIs.


ABSTRACT: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis calls for an immediate search for novel treatment strategies. Recently, BlaC, the principal beta-lactamase of Mycobacterium tuberculosis, was recognized as a potential therapeutic target. BlaC belongs to Ambler class A, which is generally susceptible to the beta-lactamase inhibitors currently used in clinics: tazobactam, sulbactam, and clavulanate. Alterations at Ser130 in conserved SDN loop confer resistance to mechanism-based inhibitors (MBIs) commonly observed in various clinical isolates. The absence of clinical evidence of S130G conversion in M. tuberculosis draws our attention to build laboratory mutants of S130G and S130A of BlaC. The study involving steady state, inhibition kinetics, and fluorescence microscopy shows the emergence of resistance against MBIs to the mutants expressing S130G and S130A. To understand the molecular reasoning behind the unavailability of such mutation in real life, we have used circular dichroism (CD) spectroscopy, differential scanning calorimetry (DSC), molecular dynamics (MD) simulation, and stability-based enzyme activity to compare the stability and dynamic behaviors of native and S130G/A mutant form of BlaC. A significant decrease in melting temperature (BlaC T M 60°C, S130A T M 50°C, and S130G T M 45°C), kinetic instability at higher temperature, and comparative dynamic instability correlate the fact that resistance to beta-lactam/beta-lactamase inhibitor combinations will likely not arise from the structural alteration of BlaC, therefore establishing confidence that this therapeutic modality can be potentially applied as a part of a successful treatment regimen against M. tuberculosis.

SUBMITTER: Bhattacharya S 

PROVIDER: S-EPMC8531524 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Variations in the SDN Loop of Class A Beta-Lactamases: A Study of the Molecular Mechanism of BlaC (<i>Mycobacterium tuberculosis</i>) to Alter the Stability and Catalytic Activity Towards Antibiotic Resistance of MBIs.

Bhattacharya Sourya S   Junghare Vivek V   Pandey Niteesh Kumar NK   Baidya Subhecchha S   Agarwal Harsha H   Das Neeladrisingha N   Banerjee Ayan A   Ghosh Debashish D   Roy Partha P   Patra Hirak K HK   Hazra Saugata S  

Frontiers in microbiology 20211008


The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis calls for an immediate search for novel treatment strategies. Recently, BlaC, the principal beta-lactamase of <i>Mycobacterium tuberculosis</i>, was recognized as a potential therapeutic target. BlaC belongs to Ambler class A, which is generally susceptible to the beta-lactamase inhibitors currently used in clinics: tazobactam, sulbactam, and clavulanate. Alterations at Ser130 in conserved SDN loop confe  ...[more]

Similar Datasets

| S-EPMC4538473 | biostudies-literature
| S-EPMC2258531 | biostudies-literature
| S-EPMC7418532 | biostudies-literature
| S-EPMC9112487 | biostudies-literature
| S-EPMC7737660 | biostudies-literature
| S-EPMC8060031 | biostudies-literature
| S-EPMC1219177 | biostudies-other
| S-EPMC64673 | biostudies-literature
| S-EPMC1136623 | biostudies-other
| S-EPMC6995641 | biostudies-literature